1. Home
  2. RGCO vs TNXP Comparison

RGCO vs TNXP Comparison

Compare RGCO & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

HOLD

Current Price

$21.53

Market Cap

214.4M

Sector

Utilities

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$19.01

Market Cap

194.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGCO
TNXP
Founded
1912
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.4M
194.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RGCO
TNXP
Price
$21.53
$19.01
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$70.00
AVG Volume (30 Days)
12.0K
482.8K
Earning Date
02-09-2026
11-10-2025
Dividend Yield
3.96%
N/A
EPS Growth
11.26
N/A
EPS
1.29
N/A
Revenue
$95,334,212.00
$10,299,000.00
Revenue This Year
$6.03
$7.00
Revenue Next Year
$2.73
$718.07
P/E Ratio
$17.04
N/A
Revenue Growth
12.63
N/A
52 Week Low
$19.50
$6.76
52 Week High
$23.82
$69.97

Technical Indicators

Market Signals
Indicator
RGCO
TNXP
Relative Strength Index (RSI) 47.37 63.32
Support Level $21.10 $15.74
Resistance Level $22.34 $17.07
Average True Range (ATR) 0.48 1.04
MACD 0.07 0.40
Stochastic Oscillator 42.86 81.44

Price Performance

Historical Comparison
RGCO
TNXP

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: